CFTC Rejects CME’s “Perpetual Contracts Aren’t Futures” Claim: No Expiry Date Doesn’t Harm Market
UpGateNeutralRegulation & policy

CFTC Rejects CME’s “Perpetual Contracts Aren’t Futures” Claim: No Expiry Date Doesn’t Harm Market

Reading time: 3 min

CFTC Pushes Back Against CME Group in Perpetual Futures Dispute

The U.S. Commodity Futures Trading Commission (CFTC) has filed new legal documents in court, challenging CME Group’s lawsuit against the regulator’s policy on perpetual futures contracts. The CFTC argues that CME lacks the standing to question the status of perpetual futures because it has not demonstrated that the new policy has caused it financial harm.

This legal battle stems from the CFTC’s decision in May to permit perpetual futures contracts in the U.S., greenlighting Kalshi to launch the first Bitcoin perpetual futures. CME Group immediately contested this, asserting that perpetual contracts, lacking an expiration date, are fundamentally swaps rather than futures and should therefore be subject to a different regulatory framework.

In its latest court filing, the CFTC contends that CME’s argument is unconvincing. “A mere assertion of increased competition, without a reasonable inference of impending financial loss, is insufficient to confer standing on CME,” the filing states. The CFTC also pointed out that CME’s own cryptocurrency futures trading volume actually increased following the policy adjustment.

The CFTC highlighted an apparent contradiction in CME’s position: the exchange tells investors there is “no demand for perpetual contracts” while simultaneously claiming these contracts compete with futures. The CFTC views this stance as inconsistent, stating, “CME cannot present one narrative in court and another during earnings calls.”

Jaret Seiberg, a policy analyst at TD Cowen, noted in a client report that CME holds advantages in its arguments regarding competition and the definition of futures. However, he also cautioned that new markets are accelerating their growth. “What is becoming increasingly concerning to me is the growth of perpetual contracts during the course of this litigation,” Seiberg wrote. “If this trend continues, it will be more difficult to reverse the market in the future.”

The CFTC had previously requested a federal judge dismiss CME’s case in filings last month. Friday’s submission elaborates on CME’s alleged lack of standing, asserting that the exchange “has not even done so” in reasonably demonstrating actual or impending increased competition.

CME’s stance has implications for market development. Perpetual contracts have become a dominant trading instrument for crypto derivatives in overseas markets. The CFTC’s policy, announced in the Federal Register, paves the way for domestic perpetual futures.

The core mechanism of perpetual contracts involves a funding rate to maintain price anchoring, without a fixed expiration date. For investors, this eliminates the need to close or roll over positions at expiration, offering a trading experience closer to that of foreign exchange markets. CME, however, argues that this structure is more akin to a swap, as contracts without expiration dates traditionally fall closer to the definition of swaps in derivative classifications.

The CFTC’s central counterargument revolves around the classification of “futures versus swaps.” If CME prevails, the U.S. could see two distinct regulatory frameworks, potentially impacting the long-term development of the crypto derivatives market. It is noteworthy that the dispute between CME and the CFTC extends beyond theoretical definitions; if the growth of perpetual contracts continues to accelerate, the cost of reversing market trends will increase.

Tags:UpGateNeutralRegulation & policy
Copied